Volume 6, Issue 3 (2017)                   WJPS 2017, 6(3): 343-350 | Back to browse issues page

XML Persian Abstract Print


1- Department of General and Vascular Surgery, Shohada-e-Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran , khoshnevis.j@gmail.com
2- Department of Health Service Management, Clinical Research Development Center of Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Department of Community Medicine, Shahid Beheshti University of Medical Sciences and Health Services, Shohadaye Tajrish Hospital, Tehran, Iran
4- Department of General and Vascular Surgery, Shohada-e-Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:   (5335 Views)
BACKGROUND
Due to shortage of local donor tissue and unreliable blood supply, free flaps were the mainstay of treatment for tissue defects in the lower leg and foot region, but it requires a qualified microvascular surgeon. Recently, attention has been paid to reverse superficial sural artery flap (RSSAF) and its modifications as a good alternative to pave the way to simple and friendly techniques.
METHODS
Excluding each patient with septic and severely ischemic foot, every patient with tissue defect in distal leg and proximal foot region were studied. Various methods were applied including spout technique with sufficient follow up. No imaging was used to evaluate the blood supply.
RESULTS
Five patients underwent spout technique with excellent results in four cases. Spout technique in one case failed due to narrow base. In five cases, RSSAF was performed with creating skin tunnel and very good results.
CONCLUSION
RSSAF is a good alternative for free flap to cover the leg and foot tissue defects. We also advise wide base pedicle (>4 cm) in every patient. 
Full-Text [PDF 5828 kb]   (2139 Downloads)    
Type of Study: Original Article | Subject: General
ePublished: 2017/10/23

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.